IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 41 a 60 di 77
Titolo Data di pubblicazione Autore(i) File
Decreased circulating interleukin-33 concentration in Helicobacter pylori-infected patients with peptic ulcer: Evaluation of its association with a cytokine gene polymorphism, gender of patients and bacterial virulence factor CagA 1-gen-2019 Bassagh, A.; Jafarzadeh, A.; Kazemipour, N.; Nemati, M.; Aminizadeh, N.; Larussa, T.; Ghazizadeh, M.; Abasi, M. H.; Mirkamandar, E.
Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centers 1-gen-2019 Tursi, A; Mocci, G; Faggiani, R; Allegretta, L; Valle, Nd; Forti, G; Franceschi, M; Ferronato, A; Gallina, S; Larussa, T; Luzza, F; Lorenzetti, R; Penna, A; Rodino, S; Sebkova, L; Lauria, A; Piergallini, S; Pranzo, G; Ricciardelli, C; Zampaletta, C; Elisei, W; Picchio, M
Use of Complementary and Alternative Medicine by Patients with Irritable Bowel Syndrome According to the Roma IV Criteria: A Single-Center Italian Survey 1-gen-2019 Larussa, T; Rossi, M; Suraci, E; Marasco, R; Imeneo, M; Luzza, F; Montebianco Abenavoli, L
Self-Prescribed Dietary Restrictions are Common in Inflammatory Bowel Disease Patients and Are Associated with Low Bone Mineralization 1-gen-2019 Larussa, T; Suraci, E; Marasco, R; Imeneo, M; Abenavoli, L; Luzza, F
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 1-gen-2019 Larussa, T.; Palleria, C.; Naturale, M. D.; Vero, A.; Manti, A.; Iannone, L.; Spagnuolo, R.; Doldo, P.; Citraro, R.; Russo, E.; Abenavoli, L.; De Sarro, G.; Luzza, F.
Olive Tree Biophenols in Inflammatory Bowel Disease: When Bitter is Better 1-gen-2019 Larussa, T; Imeneo, M; Luzza, F
Beneficial effects of coffee in non-alcoholic fatty liver disease: a narrative review 1-gen-2020 Calabrò, Alessio; Procopio, Anna Caterina; Primerano, Francesco; Larussa, Tiziana; Luzza, Francesco; Di Renzo, Laura; De Lorenzo, Antonino; Gualtieri, Paola; Abenavoli, Ludovico
Liver Cirrhosis Complications Management At The Emergency Department 1-gen-2020 Scarpellini, E; Luigiano, C; Svegliati-Baroni, G; Dumitrascu, D; Larussa, T; Santori, V; Luzza, F; Abenavoli, Ludovico.
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 1-gen-2020 Roberti, R.; Iannone, L. F.; Palleria, C.; De Sarro, C.; Spagnuolo, R.; Barbieri, M. A.; Vero, A.; Manti, A.; Pisana, V.; Fries, W.; Trifiro, G.; Naturale, M. D.; Larussa, T.; De Francesco, A. E.; Bosco, V.; Donato di Paola, E.; Citraro, R.; Luzza, F.; Bennardo, L.; Rodino, S.; Doldo, P.; Spina, E.; Russo, E.; De Sarro, G.
Safety profile of intravenous iron in inflammatory bowel disease: an up-to-date overview 1-gen-2020 Spagnuolo, Rocco; Abenavoli, Ludovico; Larussa, Tiziana; Iannelli, Chiara; Pellicano, Rinaldo; Fagoonee, Sharmila; Doldo, Patrizia; Luzza, Francesco
Potential role of fecal gluten immunogenic peptides to assess dietary compliance in celiac patients 1-gen-2020 Larussa, Tiziana; Boccuto, Luigi; Luzza, Francesco; Abenavoli, Ludovico
Barriers And Facilitators In Conducting Clinical Trials In Inflammatory Bowel Disease: A Monocentric Italian Survey. 1-gen-2020 Larussa, T; Suraci, E; Marasco, R; Imeneo, M; Dumitrascu, Dl; Abenavoli, L; Luzza, F.
A Framework for Patient Data Management and Analysis in Randomised Clinical Trials 1-gen-2020 Guzzi, P. H.; Larussa, T.; Vallelunga, R.; Montebianco Abenavoli, L.; Tradigo, G.; Luzza, F.; Veltri, P.
COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey 1-gen-2020 Spagnuolo, Rocco; Larussa, Tiziana; Iannelli, Chiara; Cosco, Cristina; Nisticò, Eleonora; Manduci, Elena; Bruno, Amalia; Boccuto, Luigi; Abenavoli, Ludovico; Luzza, Francesco; Doldo, Patrizia
Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic. 1-gen-2020 Scarpellini, Emidio; Fagoonee, Sharmila; Rinninella, Emanuele; Rasetti, Carlo; Aquila, Isabella; Larussa, Tiziana; Ricci, Pietrantonio; Luzza, Francesco; Abenavoli, Ludovico
The Reality of Patient-Reported Outcomes of Health-Related Quality of Life in an Italian Cohort of Patients with Inflammatory Bowel Disease: Results from a Cross-Sectional Study 1-gen-2020 Larussa, T; Flauti, D; MONTEBIANCO ABENAVOLI, Ludovico; Boccuto, L; Suraci, E; Marasco, R; Imeneo, M; Luzza, F.
The protective effects of resveratrol on ulcerative colitis via changing the profile of Nrf2 and IL-1β protein 1-gen-2020 Sabzevary-Ghahfarokhi, Milad; Soltani, Amin; Luzza, Francesco; Larussa, Tiziana; Rahimian, Ghorbanali; Shirzad, Hedayatollah; Bagheri, Nader
Increased Indoleamine 2, 3-Dioxygenase expression modulates Th1/Th17/Th22 and Treg pathway in humans with Helicobacter Pylori-Infected gastric mucosa 1-gen-2020 Azadegan-Dehkordi, F.; Shirzad, H.; Ahmadi, R.; Bashash, D.; Abdollahpour-Alitappeh, M.; Luzza, F.; Larussa, T.; Nahid-Samiei, M.; Rahimian, G.; Shafigh, M. -H.; Bagheri, N.
Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series. 1-gen-2021 Larussa, T; Basile, A; Palleria, C; Iannelli, C; Vero, A; Giubilei, L; De Sarro, C; Suraci, E; Marasco, R; Imeneo, M; Russo, E; MONTEBIANCO ABENAVOLI, Ludovico; De Sarro, G; Luzza, F.
Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives 1-gen-2021 Dallio, M; Romeo, M; Gravina, Ag; Masarone, M; Larussa, T; MONTEBIANCO ABENAVOLI, Ludovico; Persico, M; Loguercio, C; Federico, A.
Mostrati risultati da 41 a 60 di 77
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile